Patient Guide: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06031441
Status: 🟢 Enrolling Now
Condition: Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors
Phase: PHASE1

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • New Haven, Connecticut
  • • New York, New York
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors - Join Clinical Trial NCTNCT06031441

How to Join This Clinical Trial - NCTNCT06031441

Learn how to participate in this PHASE1 trial studying an investigational therapy for Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06031441 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06520 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10029 - United States

Status: RECRUITING

Clinical Research Site

Nashville, Tennessee 37203 - United States

Status: RECRUITING

Clinical Research Site

Darlinghurst, New South Wales 2010 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 3000 - Australia

Status: RECRUITING

Clinical Research Site

Vancouver, British Columbia V5Z 4E6 - Canada

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M5G 1Z5 - Canada

Status: RECRUITING

Clinical Research Site

London, EC1A 7BE - United Kingdom

Status: RECRUITING

Clinical Research Site

London, W1G 6AD - United Kingdom

Status: RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships